Home blood glucose monitoring in type 2 diabetes — Reynolds and Strachan 329 (7469): 754 — BMJ – “If the scientific evidence supporting the role of home blood glucose monitoring in type 2 diabetes was subject to the same critical evaluation that is applied to new pharmaceutical agents, then it would perhaps not have been approved for use by patients.” The emphasis on diabetes as “the” use case for remote monitoring may be misguided. This editorial discusses how we’ve gotten there (no one reimburses for blood pressure monitors, they do for diabetic test strips….)